vTv’s Azeliragon is Latest Alzheimer’s Drug Failure

Roquette, the France-based supplier of plant-based ingredients for food, nutrition and health markets, has launched two new wheat-free directly compressible grades of Mannitol/a>. Mumbai-based Signet Chemical Corporation Pvt. Ltd. is the authorised distributor for the products in India.
The company has been investing in excipient innovation for the growing nutraceutical industry. It is seeking to address the growing consumer preference for clean label products like natural, organic, allergen-free, where in gluten-free products are also being increasingly preferred by consumers in general and particularly by those with dietary restrictions or celiac diseases.
According to Roquette, the two new grades – Pearlitol SW-F 100 and Pearlitol SW-F 200 – have comparable direct compression performance as that of Pearlitol 100 SD and Pearlitol 200 SD (spray-dried mannitol) grades, which are the preferred excipients due to properties like optimum flow, compressibility, high chemical compati-bility and non-hygroscopicity. Spray-dried mannitol is soluble in nature, has absence of unstable crystalline form and also has a negative heat of solution, which gives a cooling effect and pleasant taste to nutraceutical tablets.
Roquette offers a broad range of natural, functional filler/binder and taste-masking excipients that provide pleasant taste, mouth-feel and solid or liquid oral dosage form choice (syrup, lozenge, ODT, ODF, effervescent, gummy). With three innovation centres across the globe, Roquette is continuously investing in designing multi-functional excipients and ready to use co-processed platforms to meet customer needs. The company has leveraged its secure global supply chain and scale-up competency in spray-drying to innovate new solutions and have strengthened their position in the nutraceutical industry. Products formulated with the new Pearlitol SW-F grades can be claimed to be gluten-free, tooth-friendly, sugar free and non-GMO, it said.
Looking for chemical products? Let suppliers reach out to you!
2026-06-29
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
US Vietnam Trade Deal Slashes Tariffs to 20 Percent Avoids Economic Clash
-
US Resumes Ethane Exports to China 240000 Barrels Per Day Back on Track
-
AbbVie Invests $2.1 Billion in Capstan Therapeutics Transforming CAR-T Landscape
-
32 Pharma Deals in 2025 First Half Signal Industry Shift Amid Policy Uncertainty
-
Innogen Targets 2026 Obesity Drug Market With Trials to Wrap in 2025
Recommend Reading
-
China Signals Openness to WTO Reforms Tariff Talks Ahead of 2026 Meeting
-
China Extends Anti-Dumping Duties Up to 103.1 Percent on Steel Imports
-
NHU Projects Profit Surge of Up to 70 Percent in H1 2025 Reaching 37.5 Billion Yuan
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
BASF Raises API and Excipient Prices
-
BASF Opens Up PolyTHF® Technology: A Quiet but Powerful Shake-Up in the Global Fibers Game
-
This Week's Activated Carbon Prices Rise (11.17-11.21)
-
Weak Demand Leads to a Decline in n-Butanol Prices in China
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices